HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hungarian Psychiatrists' Recognition, Knowledge, and Treatment of Catatonia.

Abstract
DSM-5 introduced a number of modifications to the catatonic syndrome, which is now closer to Kahlbaum's original concept. The aim of the present study was to assess residents' and qualified psychiatrists' knowledge, experience and views about the treatment of catatonia in acute psychiatric care in Budapest, Hungary. Authors approached all psychiatric units that provide acute psychiatric care (N = 11) in Budapest and invited all psychiatrists and residents, who consented, to participate in the survey, completing a 13 items questionnaire. Ninety-eight fully qualified and trainee psychiatrists completed the questionnaire. Although 84.7% of the participants rated their knowledge of catatonia as moderate or significant, there were a number of obvious mistakes in their answers. Most catatonic signs and symptoms were not identified by almost 50% of the respondents and the frequency of catatonia was also underestimated. The views of the majority of the participants reflected the Kraepelinian concept, in which catatonia is primarily associated with schizophrenia. Although benzodiazepines are widely recommended as a first line treatment for catatonia, only 69.4% of participants chose them as a treatment option. In view of its clinical importance, catatonia deserves more attention in the education and training of medical students and psychiatric residents.
AuthorsRozália Takács, Gabor S Ungvari, Anna Z Antosik-Wójcińska, Gábor Gazdag
JournalThe Psychiatric quarterly (Psychiatr Q) Vol. 92 Issue 1 Pg. 41-47 (03 2021) ISSN: 1573-6709 [Electronic] United States
PMID32445003 (Publication Type: Journal Article)
Chemical References
  • Benzodiazepines
Topics
  • Adult
  • Aged
  • Benzodiazepines (therapeutic use)
  • Catatonia (complications, diagnosis, therapy)
  • Clinical Competence
  • Female
  • Humans
  • Hungary
  • Male
  • Middle Aged
  • Psychiatry (education)
  • Schizophrenia (complications)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: